[HTML][HTML] Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

G Pistritto, D Trisciuoglio, C Ceci, A Garufi… - Aging (albany …, 2016 - ncbi.nlm.nih.gov
Apoptosis is a form of programmed cell death that results in the orderly and efficient removal
of damaged cells, such as those resulting from DNA damage or during development …

Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia

Y Liu, Z Cheng, Y Pang, L Cui, T Qian, L Quan… - Journal of hematology & …, 2019 - Springer
Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …

RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia

C Shen, Y Sheng, AC Zhu, S Robinson, X Jiang… - Cell stem cell, 2020 - cell.com
Summary N 6-methyladenosine (m 6 A), the most abundant internal modification in mRNA,
has been implicated in tumorigenesis. As an m 6 A demethylase, ALKBH5 has been shown …

FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase

Z Li, H Weng, R Su, X Weng, Z Zuo, C Li, H Huang… - Cancer cell, 2017 - cell.com
Summary N 6-Methyladenosine (m 6 A) represents the most prevalent internal modification
in mammalian mRNAs. Despite its functional importance in various fundamental …

[HTML][HTML] MicroRNAs in apoptosis, autophagy and necroptosis

Z Su, Z Yang, Y Xu, Y Chen, Q Yu - Oncotarget, 2015 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are endogenous 22 nt non-coding RNAs that target mRNAs for
cleavage or translational repression. Numerous miRNAs regulate programmed cell death …

MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts

JA Wallace, RM O'Connell - … Journal of the American Society of …, 2017 - ashpublications.org
Acute myeloid leukemia (AML) is a deadly hematologic malignancy characterized by the
uncontrolled growth of immature myeloid cells. Over the past several decades, we have …

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

A Zhao, H Zhou, J Yang, M Li, T Niu - Signal Transduction and Targeted …, 2023 - nature.com
Hematologic malignancies are one of the most common cancers, and the incidence has
been rising in recent decades. The clinical and molecular features of hematologic …

[HTML][HTML] Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway

D Ren, B Lin, X Zhang, Y Peng, Z Ye, Y Ma, Y Liang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Emerging studies indicated that cancer stem cells represent a subpopulation of cells within
the tumor that is responsible for chemotherapeutic resistance. However, the underlying …

miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer

G Liang, W Meng, X Huang, W Zhu… - Proceedings of the …, 2020 - National Acad Sciences
Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell
lung cancer (NSCLC) accounts for over 80% of lung cancer cases. The RNA binding protein …

TET1 plays an essential oncogenic role in MLL-rearranged leukemia

H Huang, X Jiang, Z Li, Y Li, CX Song… - Proceedings of the …, 2013 - National Acad Sciences
The ten-eleven translocation 1 (TET1) gene is the founding member of the TET family of
enzymes (TET1/2/3) that convert 5-methylcytosine to 5-hydroxymethylcytosine. Although …